Matthew Frankel

Matthew Frankel

No más puestos en curso
58 años
Health Technology
Consumer Services

Perfil

Matthew B. Frankel formerly worked at Reata Pharmaceuticals, Inc., as Global Medical Director from 2010 to 2012, Boehringer Ingelheim Pharmaceuticals, Inc., as VP-Clinical Development & Medical Affairs from 2018 to 2022, Novartis Pharmaceuticals Corp., as VP, Head-Immunology & Dermatology from 2016 to 2018, and Chemomab Therapeutics Ltd., as Chief Medical Officer & VP-Drug Development from 2022 to 2025.
Dr. Frankel received his undergraduate degree from Vassar College, doctorate degree from David Geffen School of Medicine, and Masters Business Admin degree from Kellogg School of Management.

Antiguos cargos conocidos de Matthew Frankel.

EmpresasCargoFin
CHEMOMAB THERAPEUTICS LTD. Director Técnico/Científico/I+D 15/04/2025
Director Técnico/Científico/I+D 01/11/2022
Corporate Officer/Principal 01/01/2018
REATA PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 01/01/2012
Ver el detalle de la experiencia de Matthew Frankel.

Formación de Matthew Frankel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

18

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology